CDKN1A and hepatocellular carcinoma: This is also consistent with the study reported by Huang et al. (2016) that the low expression of VRK1 in hepatocellular carcinoma can stabilize p53, thereby promoting the expression of P21, causing necessary cell cycle arrest and leading to a better prognosis.